Position history for Polar Capital Holdings Plc's holdings in REGENERON PHARMACEUTICALS
Polar Capital Holdings Plc holds 192,546 shares of REGN (REGENERON PHARMACEUTICALS), worth $148.8M as of 2026-Q1. The position was decreased (-6.0% shares). REGN represents 0.5% of Polar Capital Holdings Plc's portfolio.
Current Value
$148.8M
Current Shares
192,546
Total Value Change
+$8.9M
Total Shares Change
+59,515
Other major holders of REGN: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Decreased |
| 192,546 |
-6.0% |
| $148.8M |
| 0.5% |
| $766.66 |
0 |
| 2025-Q4 | Increased | 204,927 | +29.0% | $158.2M | 0.6% | $773.94 | 54 |
| 2025-Q3 | Increased | 158,817 | +126.9% | $89.3M | 0.4% | $560.05 | 58 |
| 2025-Q2 | Increased | 70,000 | +27.3% | $36.8M | 0.2% | $519.56 | 43 |
| 2025-Q1 | Decreased | 55,000 | -2.2% | $34.9M | 0.2% | $634.66 | 0 |
| 2024-Q4 | Decreased | 56,249 | -21.6% | $40.1M | 0.2% | $698.71 | 0 |
| 2024-Q3 | Decreased | 71,795 | -46.0% | $75.5M | 0.4% | $1,036.94 | 0 |
| 2024-Q2 | Decreased | 133,031 | -24.8% | $139.8M | 0.8% | $1,045.23 | 0 |